An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

NCT00094770 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1172

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: sitagliptin (MK0431)
DRUG: Comparator: glipizide

Sponsor

Merck Sharp & Dohme LLC